papmet: met inhibitors in treating papillary renal cell carcinoma
Published 3 years ago • 810 plays • Length 2:35Download video MP4
Download video MP3
Similar videos
-
5:16
potential new treatments in renal cell carcinoma
-
1:34
unmet needs in the treatment of renal cell carcinoma
-
1:26
what is papillary rcc?
-
2:15
kidney cancer at asco gu: papmet & clear
-
2:16
savolitinib plus durvalumab show promise in papillary renal cancer: calypso results
-
1:12
papillary kidney cancer: prognosis & therapy efficacy
-
5:01
papillary kidney cancer clinical trials
-
1:17
treating non-clear cell renal cell carcinoma patients
-
1:16
the challenges in treating renal cell carcinoma
-
1:42
current treatment landscape in renal cell carcinoma
-
2:03
dr. choueiri on savolitinib in papillary renal cell cancer
-
2:13
actionable genomic alterations in rcc
-
1:23
checkmate 9er: nivolumab with cabozantinib in renal cell carcinoma
-
0:37
papillary renal cell carcinoma (medical condition)
-
0:55
the evolving treatment landscape of renal cell carcinoma
-
2:32
len pembro metastatic clear cell renal cell carcinoma
-
1:12
cabozantinib for advanced renal cell carcinoma: the meteor and cabosun trials
-
2:35
cabozantinib most effective treatment for metastatic papillary kidney cancer
-
3:45
crizotinib for advanced papillary renal cell carcinoma with met mutations or amplification